SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

CytoDyn Presents Updated Leronlimab Data at ESMO Congress

The Phase 2 CLOVER study enrolled 66 patients across seven sites in metastatic colorectal cancer.

CYDY

Related stories